Our mAb acts on cells with elevated TIGIT expression, and this mechanism shows that the mAb can directly suppress the activation of autoreactive T cells in autoimmune diseases, even if the self-antigen is unknown. The gene discussed is TIGIT; the disease is autoimmune disease.